Dual Gatekeepers-Modified Mesoporous Organic Silica Nanoparticles for Synergistic Photothermal-Chemotherapy of Breast Cancer.

Wei Wang,Fengmin Zhong,Dun Wang,Yuqi Zhao,Dongdong Peng,Shuang Li,Qian Ning,Shengsong Tang,Cui-Yun Yu,Hua Wei

DOI: https://doi.org/10.1016/j.jcis.2023.05.018

IF: 9.9

2023-01-01

Journal of Colloid and Interface Science

Abstract:Hypothesis: Construction of dual gatekeepers-functionalized mesoporous organic silica nanoparticles (MONs) with both physical and chemical mechanisms for modulated drug delivery properties provides one solution to the extracellular stability vs. intracellular high therapeutic efficiency of MONs that hold great potential for clinical translations. Experiments: We reported herein facile construction of diselenium-bridged MONs decorated with dual gatekeepers, i.e., azobenzene (Azo)/polydopamine (PDA) for both physical and chemical modulated drug delivery properties. Specifically, Azo can act as a physical barrier to block DOX in the mesoporous structure of MONs for extracellular safe encapsulation. The PDA outer corona serves not only as a chemical barrier with acidic pHmodulated permeability for double insurance of minimized DOX leakage in the extracellular blood circulation but also for inducing a PTT effect for synergistic PTT and chemotherapy of breast cancer. Findings: An optimized formulation, DOX@(MONs-Azo3)@PDA resulted in approximately 1.5 and 2.4 fold lower IC50 values than DOX@(MONs-Azo3) and (MONs-Azo3)@PDA controls in MCF-7 cells, respectively, and further